Send the following on WhatsApp
Continue to Chathttps://www.marketscreener.com/quote/stock/XENCOR-INC-14917391/news/Xencor-Inc-Presents-Clinical-Results-from-Phase-1a-Study-of-XmAb-564-at-the-EULAR-2023-Congress-43998686/?utm_source=whatsapp&utm_medium=social&utm_campaign=share